Antharis Therapeutics is a biopharmaceutical company developing new treatments for catastrophic diseases including cancer, as well as neurological and inflammatory disorders. The company was founded and is led by a multi-disciplinary PhD scientist with extensive experience as a researcher and as an executive in relevant investment firms. The company uses cutting-edge science to develop therapeutic monoclonal antibodies with the end goal of efficiently treating unmet medical needs.

Dr. Raphael Ribeiro-Pinaud, PhD